Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of hepatitis B. Practical implications]

H A Kühn

    Schweizerische Medizinische Wochenschrift
    |April 16, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Currently, no specific viral hepatitis treatment exists, but prevention strategies like vaccination are advancing. Chronic active hepatitis shows promise with immunosuppressive therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hypochloraemia and chloroprive tetany due to persistent vomiting in duodenal stenosis due to ulcer scar.

    Medizinische Klinik·2010
    Same author

    Columnar-lined oesophagus (Barrett's syndrome) - congenital or acquired?

    Endoscopy·1981
    Same author

    [Clinical medicine education today: the dilemma of patient-oriented practice].

    Die Medizinische Welt·1980
    Same author

    [Alcohol and liver diseases].

    Medizinische Klinik·1980
    Same author

    [Virus hepatitis, an overview (author's transl)].

    Leber, Magen, Darm·1980
    Same author

    [Etiology, complications and prognosis of liver cirrhosis in 917 patients. II. Causes of death and prognosis in liver cirrhosis].

    Lebensversicherungs Medizin·1979

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Context:

    • Viral hepatitis lacks specific treatments, necessitating supportive care and isolation.
    • Fulminant hepatic failure management remains controversial, with ongoing research into glucocorticoid and serum treatments.
    • Chronic active hepatitis presents complex treatment challenges, requiring tailored immunomodulatory approaches.

    Purpose:

    • To review current management strategies for viral hepatitis, including supportive care, specific therapies for chronic active hepatitis, and emerging prevention methods.
    • To evaluate the efficacy of various treatments for different forms of viral hepatitis, from uncomplicated cases to fulminant hepatic failure.
    • To explore the potential of active immunization for hepatitis B prevention.

    Summary:

    Related Experiment Videos

  • Uncomplicated viral hepatitis requires rest and isolation; fulminant hepatic failure treatment is debated. Chronic active hepatitis responds well to azathioprine and glucocorticoids.
  • Immunomodulatory agents like transfer factor, levamisole, and thymosin are under investigation for chronic active hepatitis.
  • Hepatitis B prevention through active immunization shows promise, contingent on developing effective vaccine production methods.

    • Impact:

    • Highlights the need for effective viral hepatitis treatments and preventative measures, particularly for hepatitis B.
    • Informs clinical practice regarding the management of chronic active hepatitis and fulminant hepatic failure.
    • Underscores the critical role of vaccine development in controlling hepatitis B infections.